Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BOIRON Interim / Quarterly Report 2016

Apr 28, 2016

1161_10-q_2016-04-28_95ade3d2-eac2-4ed4-832a-8dcb43692edb.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

2016 FIRST QUARTER BOIRON ACTIVITY

(Unaudited data)

in thousands of euros 2015 2016 Variation at
current
exchange rates
Variation at
constant
exchange
rates
France 89,584 90,494 +1.0% +1.0%
Europe (excluding France) 40,657 43,685 +7.4% +12.5%
North America 17,193 16,064 -6.6% -7.3%
Other countries 4,622 3,846 -16.8% -13.0%
Group total 152,056 154,089 +1.3% +2.7%
in thousands of euros 2015 2016 Variation at
current
exchange rates
Variation at
constant
exchange
rates
Non-proprietary Homeopathic Medicines 79,191 80,147 +1.2% +1.2%
OTC Specialties 72,880 73,743 +1.2% +4.1%
Other -15 199 - -
Group total 152,056 154,089 +1.3% +2.7%

HIGHLIGHTS OF THE FIRST QUARTER

Sales in the first quarter of 2016 rose by 1.3% compared to the first quarter of 2015 (+2.7% at constant rate).

Our Company continues with the same passion the development of homeopathy in the world. For the current year, we remain cautious on the development of sales and result.

Our next updates:

May 19, 2016 at 10:30 am, at BOIRON headquarters, 2 avenue de l'Ouest Lyonnais, 69510 MESSIMY – FRANCE: Ordinary Shareholders' Meeting.

June 3, 2016: after approval by the Ordinary Shareholders' Meeting, payment of the proposed dividend (€1.50 per share). July 19, 2016: after the close of the stock market, publication of the sales on June 30, 2016.

Person responsible for financial information: Christian Boiron

Contact for financial information: Véronique Bouscayrol

Investor relations: +33 (0) 4.78.45.63.43 - e-mail : [email protected]

ISIN Code: FR0000061129 (BOI) - Bloomberg: BOI FP - Reuters: BOIR.PA

The group's financial information is online at: www.boironfinance.com